Preventative Cardiology

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy Cardiovascular Risk Reduction With GLP-1 RA Drugs Metabolic and Safety Outcomes of Statin–Ezetimibe Versus High‐Intensity Statin in Older Patients Longitudinal Associations of Cumulative Depression Burden With Cardiovascular Diseases and All‐Cause Death Among Middle‐Aged and Older Population: Evidence From 2 Nationwide Cohort Studies AHA/ACC/ESC/WHF Expert Consensus Document in Collaboration with HFSA, HFA and JHFS: Second Universal Definition of Heart Failure (2026) Researchers at Heart Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance Why We Must Rethink Universal Lp(a) Screening as a Routine Cardiovascular Prevention Strategy Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities Treating Psychological Factors in Patients With Heart Disease: Where Have We Been, How Shall We Proceed?